Biomedical Engineering, University of California, Irvine, CA 92697, USA.
Amgen Research, Biologics Therapeutic Discovery, 1 Amgen Center Drive, Thousand Oaks, California 91320, USA.
Lab Chip. 2023 May 30;23(11):2577-2585. doi: 10.1039/d3lc00101f.
Measurement of fluid viscosity represents a huge need for many biomedical and materials processing applications. Sample fluids containing DNA, antibodies, protein-based drugs, and even cells have become important therapeutic options. The physical properties, including viscosity, of these biologics are critical factors in the optimization of the biomanufacturing processes and delivery of therapeutics to patients. Here we demonstrate an acoustic microstreaming platform termed as microfluidic viscometer by acoustic streaming transducers (μVAST) that induces fluid transport from second-order microstreaming to measure viscosity. Validation of our platform is achieved with different glycerol content mixtures to reflect different viscosities and shows that viscosity can be estimated based on the maximum speed of the second-order acoustic microstreaming. The μVAST platform requires only a small volume of fluid sample (∼1.2 μL), which is 16-30 times smaller than that of commercial viscometers. In addition, μVAST can be scaled up for ultra-high throughput measurements of viscosity. Here we demonstrate 16 samples within 3 seconds, which is an attractive feature for automating the process flows in drug development and materials manufacturing and production.
测量流体粘度是许多生物医学和材料加工应用的巨大需求。包含 DNA、抗体、基于蛋白质的药物甚至细胞的样品流体已成为重要的治疗选择。这些生物制剂的物理性质,包括粘度,是优化生物制造过程和将治疗药物输送给患者的关键因素。在这里,我们展示了一种称为声流换能器(μVAST)的微流控粘度计的声微流平台,该平台通过二阶微流诱导流体传输来测量粘度。我们的平台通过不同的甘油含量混合物进行验证,以反映不同的粘度,并表明可以根据二阶声微流的最大速度来估计粘度。μVAST 平台仅需要少量的流体样品(约 1.2 μL),这比商业粘度计小 16-30 倍。此外,μVAST 可以扩展用于超高吞吐量的粘度测量。在这里,我们在 3 秒内演示了 16 个样本,这对于自动化药物开发和材料制造和生产中的过程流是一个有吸引力的特性。